Clinical Trial Update: Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD. [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing ticagrelor to clopidogrel for reducing arterial stiffness and wave reflections in patients with coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Hellenic Cardiovascular Research Society | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED